lobbying_activities: 3152466
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3152466 | d22a485a-3b69-477b-b25a-17a86f91ccbb | Q1 | HB STRATEGIES | 401104718 | BAYER U.S. LLC | 2024 | first_quarter | PHA | Provide lobbying support of key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare and agricultural industries generally and Bayer specifically. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2024-04-18T15:46:16-04:00 |